Abstract
Blood pressure (BP) control in patients with atherosclerotic cardiovascular disease reduces cardiovascular (CV) mortality. 1, 2 However, management of CV risk factors, including BP, is often sub-optimal in patients with peripheral artery disease (PAD), increasing the CV mortality associated with PAD. 3 Studies examining BP management in PAD are mostly small or subgroup analyses of cohorts with coronary disease (CAD). 4 Given the benefits of adequate BP control in high-risk patients, it is important to examine hypertension (HTN) management in cohorts with PAD. 1, 2 We used data from a multinational prospective registry of patients with PAD presenting with new or worsening symptoms at specialty vascular clinic to describe the prevalence of controlled HTN and assess for inter-site variability in achieving optimal BP control.
Funding Information
  • National Heart, Lung, and Blood Institute of the National Institutes of Health (T32HL110837)
  • National Institutes of Health
  • Merck, Abbott and Boston Scientific
  • Patient-Centered Outcomes Research Institute (IP2 PI000753-01, CE-1304-6677)
  • Netherlands Organization for Scientific Research (916.11.179)

This publication has 5 references indexed in Scilit: